Michigan Medicine notifies patients of health information breach

Compromised employee email account could have exposed health information of about 2,920 patients

Author | Mary Masson

Michigan Medicine is notifying approximately 2,920 patients about an employee email account that was compromised which may have exposed some of their health information.

On December 23, 2021, an employee’s Michigan Medicine email account was compromised, resulting in a cyber attacker gaining access to and using the account to send phishing emails. The employee did not know about the compromise until suspicious activity occurred on January 6, 2022. That same day, the employee immediately reported the situation to our Information Technology Department, and the email account was disabled.   

No evidence was uncovered during our investigation to suggest that the aim of the attack was to obtain patient health information, but data theft could not be ruled out. As a result, all of the emails involved were presumed compromised.  The contents were reviewed to determine if sensitive data about any patients was potentially impacted.  This analysis took place between January 31 through February 15, 2022.

Some emails and attachments were found to contain identifiable patient information, such as: names, medical record numbers, addresses, dates of birth, diagnostic and treatment information, and/or health insurance information. The emails were job-related communications for coordination and care of patients, and information related to a specific patient varied, depending on a particular email or attachment.  However, no social security numbers, credit card, debit card or other financial account information were discovered.

As soon as Michigan Medicine learned that the email account was compromised, the account was disabled so no further access could take place and immediate password changes were made. Additional technical safeguards on our email system and the infrastructure that supports it were also put in place to prevent similar incidents from happening. 

Robust training and education materials are used to increase employee awareness of the risks of cyberattacks, as well as how to identify and report them. We are reviewing these materials to make further improvements.

“Patient privacy is extremely important to us, and we take this matter very seriously. Michigan Medicine took steps immediately to investigate this matter and is implementing additional safeguards to reduce risk to our patients and help prevent recurrence,” said Jeanne Strickland, Michigan Medicine chief compliance officer.

Notices were mailed to the affected patients or their personal representatives starting March 3, 2022. Those concerned about the breach who do not receive a letter may call the toll-free Michigan Medicine Assistance Line: (833) 430-2163. They should refer to Engagement # B028649 when speaking with an agent.  Calls will be answered Monday through Friday, 9 am to 11 pm and Saturday – Sunday, 11 am to 8 pm (Eastern Time.) 

While Michigan Medicine does not have reason to believe the accounts were compromised for the purpose of obtaining patient information, as a precautionary measure, all affected patients have been advised to monitor their medical insurance statements for any potential evidence of fraudulent transactions. Information about potential identity theft is available from the Federal Trade Commission at www.identitytheft.gov/#/Warning-Signs-of-Identity-Theft.

About Michigan Medicine: At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our five hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and University of Michigan Health, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center, Metro Health and the Rogel Cancer Center. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

More information is available at www.uofmhealth.org

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories 10 year old boy leaning against tree and posing with his mom and sisters outside
Health Lab
Family travels over 1,000 miles for son’s heart transplant
Family travels over 1,000 miles for son's heart transplant and ongoing heart care
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Period Poverty and the Need to Make Menstruation Products Easier to Access
A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.
Health care provider with stethoscope holds patient's hand
Health Lab
Opinion: Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
An end-of-life care specialist discusses the shortfalls of hospice care coverage for people with dementia, using the experience of former President Jimmy Carter and former First Lady Rosalynn Carter as examples.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.
Illustration of a microscope
Health Lab
Researchers uncover distinct molecular subgroups of kidney disease for personalized treatment
Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.